PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
A Study Testing A Radioactive Compound Given Through A Vein With And Without The Non-Radioactive Compound, Given By Mouth, To Characterize Tissue Distribution Using Positron Emission Tomography Scanning
- Conditions
- Healthy
- Interventions
- Drug: PF-06427878 10 mgDrug: [11C]PF-06427878Drug: PF-06427878 600 mg
- First Posted Date
- 2015-04-07
- Last Posted Date
- 2015-10-29
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 8
- Registration Number
- NCT02410525
- Locations
- 🇺🇸
New Haven Clinical Research Unit, New Haven, Connecticut, United States
🇺🇸Anylan Center, New Haven, Connecticut, United States
🇺🇸Yale University School of Medicine, New Haven, Connecticut, United States
A Study Comparing The Amounts of Tafamidis In The Blood With Or Without Food
- First Posted Date
- 2015-04-02
- Last Posted Date
- 2015-08-07
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT02406560
- Locations
- 🇧🇪
Pfizer Clinical Research Unit, Brussels, Belgium
A Study to Evaluate the Pharmacodynamic Effects of Single Oral Doses of PF-06648671 on β-Amyloid (Aβ) Concentrations in Cerebrospinal Fluid (CSF)
- First Posted Date
- 2015-04-02
- Last Posted Date
- 2016-03-22
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 22
- Registration Number
- NCT02407353
- Locations
- 🇺🇸
Glendale Adventist Medical Center, Glendale, California, United States
🇺🇸California Clinical Trials Medical Group, Inc., Glendale, California, United States
PREA, PK And Safety PASS Study Of IV Pantoprazole In Pediatric Subjects
- First Posted Date
- 2015-03-27
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 19
- Registration Number
- NCT02401035
- Locations
- 🇺🇸
Children's Health Specialty Center Dallas Campus, Dallas, Texas, United States
🇺🇸Children's Medical Center Dallas, Dallas, Texas, United States
🇺🇸Primary Children's Hospital, Salt Lake City, Utah, United States
The Bioavailability of a Spray Dried Dispersion Solid Dose Formulation of PF-06260414 Relative to a Suspension Formulation
- Conditions
- Healthy
- Interventions
- Drug: PF 06260414 solid dose formulation
- First Posted Date
- 2015-03-19
- Last Posted Date
- 2018-11-14
- Lead Sponsor
- Pfizer
- Registration Number
- NCT02393807
- Locations
- 🇺🇸
Pfizer New Haven Clinical Research Unit, New Haven, Connecticut, United States
A Multiple Oral Doses Study Of PF-06427878 In Healthy Adult Subjects
- First Posted Date
- 2015-03-18
- Last Posted Date
- 2016-03-02
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 40
- Registration Number
- NCT02391623
- Locations
- 🇧🇪
Pfizer Clinical Research Unit, Brussels, Belgium
Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation
- Conditions
- Staphylococcal Vaccine
- Interventions
- Biological: Staphylococcus aureus 4-Antigen (SA4Ag) VaccineOther: Placebo
- First Posted Date
- 2015-03-13
- Last Posted Date
- 2021-01-05
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 3450
- Registration Number
- NCT02388165
- Locations
- 🇺🇸
Anne Arundel Medical Group Orthopedics and Sports Medicine Specialists, Pasadena, Maryland, United States
🇺🇸Seton Medical Center Williamson, Round Rock, Texas, United States
🇺🇸The Rothman Institute, Philadelphia, Pennsylvania, United States
A Positron Emission Tomography/Computed Tomography (PET/CT) Bone Imaging Study in Patients Receiving Enzalutamide for Castration-Resistant Prostate Cancer (CRPC)
- Conditions
- Prostate Carcinoma Metastatic to the BoneCastration Resistant Prostate Cancer
- Interventions
- First Posted Date
- 2015-03-10
- Last Posted Date
- 2020-05-05
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 23
- Registration Number
- NCT02384382
- Locations
- 🇺🇸
Karmanos Cancer Institute Weisberg Cancer Treatment Center, Farmington Hills, Michigan, United States
🇺🇸Karmanos Cancer Institute, Detroit, Michigan, United States
🇺🇸Wimr Pet/Ct, Madison, Wisconsin, United States
A Rollover Protocol of Dacomitinib For Patients In Japan
- First Posted Date
- 2015-03-09
- Last Posted Date
- 2020-07-02
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 7
- Registration Number
- NCT02382796
- Locations
- 🇯🇵
Kanazawa University Hospital, Kanazawa City, Ishikawa, Japan
🇯🇵Kurashiki Central Hospital, Kurashiki, Okayama, Japan
🇯🇵Osaka City General Hospital Department of Clinical Oncology, Osaka-city, Osaka, Japan
Study to Assess the Immunogenicity, Safety, and Efficacy of High Capacity Process Etanercept in Rheumatoid Arthritis Subjects
- Conditions
- Arthritis, Rheumatoid
- Interventions
- Biological: etanercept
- First Posted Date
- 2015-03-04
- Last Posted Date
- 2017-05-15
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 188
- Registration Number
- NCT02378506
- Locations
- 🇧🇬
UMHAT "Sv. Ivan Rilski" EAD, Sofia, Sofia, Bulgaria
🇧🇬Medical Center - "New rehabilitation center" EOOD, Stara Zagora, Bulgaria
🇭🇷Medicinski Centar Kuna Peric, Zagreb, Croatia